Detection of a dormant 20q- leukemia clone in bone marrow cultures with hematopoietic growth factors: implications for secondary leukemia post-transplant. [electronic resource]
Producer: 19970707Description: 521-3 p. digitalISSN:- 0268-3369
- Acute Disease
- Adult
- Anemia, Refractory, with Excess of Blasts -- drug therapy
- Antimetabolites, Antineoplastic -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bleomycin -- administration & dosage
- Bone Marrow -- drug effects
- Bone Marrow Transplantation
- Chromosome Deletion
- Chromosomes, Human, Pair 20 -- ultrastructure
- Clone Cells -- pathology
- Combined Modality Therapy
- Cytarabine -- therapeutic use
- Dacarbazine -- administration & dosage
- Doxorubicin -- administration & dosage
- Female
- Hematopoietic Cell Growth Factors -- pharmacology
- Hodgkin Disease -- drug therapy
- Humans
- Mechlorethamine -- administration & dosage
- Neoplasm, Residual
- Neoplasms, Second Primary -- etiology
- Neoplastic Stem Cells -- pathology
- Prednisone -- administration & dosage
- Procarbazine -- administration & dosage
- Radiotherapy -- adverse effects
- Recurrence
- Transplantation, Autologous
- Vinblastine -- administration & dosage
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.